Get started
SAREPTA THERAPEUTICS INCSAREPTA THERAPEUTICS INCSAREPTA THERAPEUTICS INC

SAREPTA THERAPEUTICS INC

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Forecast Bonds

1SRPT chart


Full chart

1SRPT upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪4.04 B‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
26.12
Basic EPS (TTM)
2.38 EUR
Net income (FY)
‪227.24 M‬ EUR
Revenue (FY)
‪1.84 B‬ EUR
Shares float
‪92.29 M‬
Beta (1Y)
1.23

Employees


Employees (FY)
‪1.37 K‬
Change (1Y)
+58 +4.41%
Revenue / Employee (1Y)
‪1.34 M‬ EUR
Net income / Employee (1Y)
‪165.62 K‬ EUR

About Sarepta Therapeutics, Inc.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Douglas S. Ingram
Website
sarepta.com
Headquarters
Cambridge
Founded
1980
FIGI
BBG01TNX7296
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

1SRPT news



Ideas



See all ideas 

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

1SRPT highest yielding bonds


SRPT5657414
Sarepta Therapeutics, Inc. 1.25% 15-SEP-2027
Yield to maturity
5.51%
Maturity date
Sep 15, 2027

See all 1SRPT bonds 

Sparks


Curated watchlists where 1SRPT is featured.

See all sparks 


Check out other big names from the same industry as 1SRPT.

Frequently Asked Questions


The current price of 1SRPT is 33.08 EUR — it has decreased by −39.59% in the past 24 hours. Watch SAREPTA THERAPEUTICS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange SAREPTA THERAPEUTICS INC stocks are traded under the ticker 1SRPT.
1SRPT stock has fallen by −38.53% compared to the previous week, the month change is a −37.93% fall, over the last year SAREPTA THERAPEUTICS INC has showed a −37.93% decrease.
We've gathered analysts' opinions on SAREPTA THERAPEUTICS INC future price: according to them, 1SRPT price has a max estimate of 167.09 EUR and a min estimate of 35.18 EUR. Watch 1SRPT chart and read a more detailed SAREPTA THERAPEUTICS INC stock forecast: see what analysts think of SAREPTA THERAPEUTICS INC and suggest that you do with its stocks.
1SRPT reached its all-time high on May 2, 2025 with the price of 55.92 EUR, and its all-time low was 53.28 EUR and was reached on Apr 25, 2025. View more price dynamics on 1SRPT chart.
See other stocks reaching their highest and lowest prices.
1SRPT stock is 65.53% volatile and has beta coefficient of 1.23. Track SAREPTA THERAPEUTICS INC stock price on the chart and check out the list of the most volatile stocks — is SAREPTA THERAPEUTICS INC there?
Today SAREPTA THERAPEUTICS INC has the market capitalization of ‪4.04 B‬, it has increased by 1.72% over the last week.
Yes, you can track SAREPTA THERAPEUTICS INC financials in yearly and quarterly reports right on TradingView.
SAREPTA THERAPEUTICS INC is going to release the next earnings report on Jul 30, 2025. Keep track of upcoming events with our Earnings Calendar.
1SRPT earnings for the last quarter are −4.25 EUR per share, whereas the estimation was −2.96 EUR resulting in a −43.44% surprise. The estimated earnings for the next quarter are 0.95 EUR per share. See more details about SAREPTA THERAPEUTICS INC earnings.
SAREPTA THERAPEUTICS INC revenue for the last quarter amounts to ‪688.50 M‬ EUR, despite the estimated figure of ‪635.46 M‬ EUR. In the next quarter, revenue is expected to reach ‪527.73 M‬ EUR.
1SRPT net income for the last quarter is ‪153.64 M‬ EUR, while the quarter before that showed ‪30.19 M‬ EUR of net income which accounts for 408.95% change. Track more SAREPTA THERAPEUTICS INC financial stats to get the full picture.
No, 1SRPT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 7, 2025, the company has ‪1.37 K‬ employees. See our rating of the largest employees — is SAREPTA THERAPEUTICS INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SAREPTA THERAPEUTICS INC EBITDA is ‪262.72 M‬ EUR, and current EBITDA margin is 14.30%. See more stats in SAREPTA THERAPEUTICS INC financial statements.
Like other stocks, 1SRPT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SAREPTA THERAPEUTICS INC stock right from TradingView charts — choose your broker and connect to your account.